Adaptimmune Therapeutics plc

ADAPY ·Healthcare, Drug Manufacturers - General
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2016 FY2015
Assets
Cash & Equivalents $158.8M $194.3M
Accounts Receivable $1.5M $744.0K
Inventory — —
Total Current Assets $198.8M $263.0M
Property, Plant & Equipment $27.9M $13.2M
Goodwill — —
Intangible Assets (Excl. Goodwill) $1.3M $305.0K
Total Assets $234.5M $285.8M
Liabilities
Accounts Payable $11.4M $7.9M
Total Current Liabilities $40.3M $27.9M
Long-Term Debt — —
Total Liabilities $68.4M $50.8M
Stockholders' Equity
Retained Earnings $-161.5M $-89.9M
Total Stockholders' Equity $166.1M $235.0M
← Newer Page 2 of 2 Older →